Showing posts with label Dtug designs. Show all posts
Showing posts with label Dtug designs. Show all posts

Friday, 8 January 2021

Lupine Publishers | Cardiovascular Risk Factors in the Population of Jamapa

 Lupine Publishers | LOJ Pharmacology & Clinical Research


 

Abstract

Introduction: Cardiovascular diseases are a group of pathologies that affect the heart and blood vessels. They represent the leading cause of death in the world and also in Mexico. Timely identification of risk factors for these diseases is important because it allows for better guidance on activities carried out by health authorities to reduce the number of avoidable deaths. Numerous studies have been conducted in this regard, however, most of them have focused on large urban communities, which makes necessary to cover otear type of populations.

Objective: To identify the presence of cardiovascular risk factors (CRF) in the population of Jamapa, Veracruz, Mexico. Material and Methods: A descriptive and cross-sectional study was conducted in 81 patients of both genders, aged 20 years or older. Glycemia, lipid profile, insulinemia and anthropometric variables were measured, insulin resistance using the HOMA-IR index was estimated and a survey was applied to register history of cardiovascular disease and lifestyle.

Results: The CRF found were overweight/obesity (74.07%), sedentaryism (74.07%), abdominal obesity (55.56%) significantly higher in women χ2(p<0.05), hypertriglyceridemia (50.6%), hypercholesterolemia (48.14%), decreased levels of c-HDL (42.00%), diabetics (38.27%) and hypertensive (34.57%). 100% of patients had at least one cardiovascular risk factor, and a maximum of nine risk factors were found in 2.5% of the total population.

Conclusion: A high prevalence of cardiovascular risk factors was observed in the population studied, and a high tendency to associate among them, denoting the need to develop strategies to address health problems in these communities.

Keywords: Cardiovascular diseases; Frequency; Risk factors; Jamapa; Veracruz

Introduction

Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels. These pathologies occur mainly as a result of a blockage of the vessels which prevents normal blood flow affecting various organs and tissues. Lipid deposits in the inner walls of vessels are the most common cause of obstruction by significantly reducing their diameter as well as their flexibility. This hardening of the arteries is known as atherosclerosis. Narrowing vessels increases the likelihood of blood clots, further contributing to vascular obstruction and decreased blog supply with subsequent organ injury [1]. The study of these diseases is of great importance today as they constitute the number one cause of mortality in the world. In 2016, 17.9 million people died of these diseases worldwide, approximately 7.4 million were due to coronary heart disease, and 6.7 million to strokes. It is projected that by 2030 almost 23.6 million people will die from some cardiovascular disease and these pathologies will continue to be the leading cause of death worldwide [2,3]. In Mexico, 25.5% of deaths in people aged <60 years are related to chronic noncommunicable diseases, specifically 19.9% corresponding to cardiovascular disease according to the National Institute of Statistic and Geography 2016, INEGI 2016, Mexico [4,5].
There are risk factors that can cause these diseases to develop, they are calle Cardiovascular Risk Factors (CRF), they can be biological, environmental, behavioral, sociocultural, economic; some are modifiable, including diabetes, hypertension, obesity and some lifestyle habits such as sedentarism and smoking; others cannot be modified as age, gender and family history. In many cases the sum of them increases their isolated effect producing a phenomenon of interaction or synergy [6]. Obviaos manifestations of cardiovascular disease, such as heart attack, stroke or others, usually appear in adulthood, however, risk factors are usually present from childhood or adolescence, terere the importance of detecting them early [7]. There are numerous studies on the prevalence of CRF, however, most of them have been conducted in large urban communities in the world, Latin America as well as in Mexico [8-10]. In this sense, it is necessary to cover different types of populations, especially those devoid of timely detection and which are prone to various health problems related to feeding conditions, economy, hygiene, housing, among others. The above justified the completion of the present study that aimed to identify the presence of cardiovascular risk factors (CRF) in the population of Jamapa, Veracruz, Mexico. Jamapa Municipality is located in the state of Veracruz, Mexico. It covers an area of 132.4Km2, and borders the north with the municipalities of Manlio Fabio Altamirano and Medellín; the east with Medellin; the south with the municipalities of Medellin and Cotaxtla; the west with Cotaxtla and Manlio Fabio Altamirano. It consists of 39 towns, 1 urban and 38 rural, the head town is Jamapa with 3,928 inhabitamos (Figure 1) [11].

 

Material and Methods

As part of a health brigade conducted by the Faculty of Bioanalysis, Region Veracruz, of the Universidad Veracruzana, a visit was made to the community of Jamapa, Veracruz, in June 2019, with the aim of detecting risk factors of cardiovascular diseases in its inhabitants. The descriptive and cross-sectional study included 81 subjects aged 20 years and older of both sexes. A survey was conducted to learn history of cardiovascular disease and lifestyle, anthropometric measurements were performed, biochemical blood tests were analyzed and the results were analyzed statistically.

Collection of information

By applying a survey with dichotomous and some open questions, information was obtained of variables such as age, sex, family and personal history of diabetes, dyslipidemias and cardiovascular disease, as well as behavioral habits such as smoking and physical activity.

Anthropometric measures

Measurement of height, weight, waist circumference and blood pressure was conducted in accordance with the manual of procedures: “Clinical and Anthropometric Measurements in the Adult and Elderly” of the Ministry of Health, Mexico. Calculation of the Body Mass Index (BMI) was made with the following formula,

BMI = weight (Kg)/ [height (m) ]2 [12].

Serum biochemical tests

After a 12-14 hour fast, blood samples were taken from the subjects, and processed in the laboratory of the Faculty of Bioanalysis, region Veracruz, Universidad Veracruzana. Glucose, total cholesterol, high-density lipoprotein cholesterol (HDL) and triglyceride were measured using colorimetric enzyme methods (Spinreact, Girona, Spain). LDL cholesterol was calculated using

Friedewald’s equation: LDLc = Total Cholesterol-HDLc - (TG/5) [13]

Insulin determination was performed using an enzyme immunoassay method (Mexlab, Mexico). Insulin resistance was calculated with the HOMA-IR index (Homeostasis Model Assesment), proposed by Matthews using the formula: HOMA-IR= fasting insulin (μUI/ml) *fasting glucose (mg/dL)/ 405 ->[14].

Clinical definitions/cut-off points

The criteria used to define cut-off points for risk factors were as follows: Age: in men ≥45 years, and in women ≥55 years. Family history: Subjects with a first-degree male family member (parent or sibling) who suffered a heart attack or other cardiovascular event before age 55 or a first-degree female relative (mother or sister) before age 65. Total serum cholesterol: ≥200 mg/dL, c-LDL: ≥130mg/dl, c-HDL: <40mg/dl, Triglycerides: ≥150mg/dl. Blood pressure: systolic ≥ 140mmHg and a diastolic ≥90mmHg, or the indication of current antihypertensive treatment. All these criteria in accordance with the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP-III) [15]. As suggested by WHO, overweight/obesity was considered with a body mass index (BMI Kg/m2), ≥25 for overweight and ≥30 for obesity [16]. Insulin resistance (HOMA-IR): >3. Sedentary, <150 minutes of moderate physical activity weekly [17]. Smoking, consumption of any tobacco product daily or occasional [18]. Finally, the diagnostic criterion of Diabetes mellitus following the recommendation of the American Diabetes Association (ADA) was fasting glucose 126mg/dL or personal history of the disease [19].

Statistical method

Risk factors were dichotomized in the form of presence versus absence. Categorical variables have been presented as percentage. Comparison of proportions was made between groups (men and women) using the Pearson Square Chi test. Continuous variables with normal distribution were presented as mean (standard deviation), non-normal variables were reported as median. The assumption of normality was assessed through the Kolmogorov- Smirnov tests and the homogeneity of variances between groups by the Levene test. Means of two continuous normally distributed variables were compared using the Student´s t test, and Mann- Whitney when the distribution was not normal. The statistical significance level was set to p<0.05 and 95% confidence intervals were calculated. The IBM SPSS version 22 program was used for statistical analysis.

Results

A total of 81 patients from the municipality of Jamapa, Veracruz, Mexico were studied; 20 (24.7%) were male and 61 (75.3%) were female. The average age was 49.04±15.86 years. The proportion of subjects presenting age of risk for cardiovascular disease was 40.74%, 74.07% showed overweight/obesity, 55.56% abdominal obesity, 74.07% sedentaryism, 50.6% hypertriglyceridemia, 48.14% hypercholesterolemia, 42.00% decreased HDL levels. Diabetics accounted for 38.27% and hypertensives 34.57%. By sex, 60% of men were at risk age against 34.42% of women, with significant difference χ2 (p <0.05). It also highlights with significant difference the higher frequency of abdominal obesity among women in relation to men χ2 (p<0.05), for the other variables studied, the Parsons Chi-saquead test showed that there is no significant difference between the proporciona of men and women (p>0.05) (Table 1). Serum insulin levels and HOMA-IR index calculation were estimated in 47 patients, 12 men and 35 women, who had any of the following parameters established as diagnostic criteria for Metabolic Syndrome by WHO: Diabetes mellitus, BMI ≥30, hypertriglyceridemia and decreased levels of c-HDL. It was found that 6 (12.8%) of the patients studied presented hiperinsulinism. By sex, 3 (25%) were men and 3 (8.6%) women. In relation to HOMA-IR, it was observed that 28 (34.57%) subjects had an index greater than 3, denoting the existence of insulin resistance.

 

100% of the subjects showed at least one cardiovascular risk factor. The highest percentage (18.5%) was observed in the group of patients with 5 risk factors, followed by the group with 3 factors (14.8%). A maximum of nine risk factors were observed in 2.5% of the total population. Figure 2 Means and medians of biochemical parameters are presented (Table 2). For total cholesterol, the mean was 204±52.41mg/dL in total population, according to gender, for women it was 204.4±45.9mg/dL, and 203±70mg/dL in men. The Student´s t test showed no significant difference between men and women (t.101, p.920). In total population a median of 41mg/dL was observed in HDL cholesterol. By sex, it was 42mg/dL in women and 38.5mg/dL in men; with no significant difference between medians (U-515.5; p-300). LDL cholesterol mean was 124.66±39.89mg/dL in total population, 126.63±37.97 in women and 118.65±45.79mg/dL in men. Student’s t-test revealed no significant difference between men and women (t.775, p.441). Regarding Triglycerides, a median of 153mg/dL was obtained in total population; by sex, it was 153mg/ dL in women, and 148.5mg/dL in men, with no significant difference between the medians of both groups. For serum glucose, a median of 87.0mg/dL was observed in the total of patients studied. Looking at both sexes, in women it was 87.0mg/dL, and in men 85mg/dL with no significant difference between them (U Mann-Whitney 581; p-0.751). Finally, with regard to serum insulin, a median of 12μlU/ ml was obtained. Comparing sexes, it was 13μlU/ml in women and 9.5μlU/ml in men, not having a significant difference between the two (U Mann-Whitney 176; p.0.406).

 

Discussion

Cardiovascular disease is the leading cause of death in the world, as well as in Mexico, so timely detection and control of their risk factors is of great importance. In this analysis, CRFs found with the highest proportion were overweight and obesity, sedentaryism, abdominal obesity, hypertriglyceridemia, hypercholesterolemia and decreased HDL-c levels. Overweight and obesity are welldocumented risk factors for cardiovascular disease. The frequency found in this study was slightly higher (74.07%), than the report in the National Mid-Way Health and Nutrition Survey 2016, ENSANUT MC 2016, in Mexico, that was (72.5%). By sex, the prevalence observed in this study was 75.0% in women, similar to ENSANUT MC 2016 (75.6%); however, the frequency observed in men in this study was 77.8%, higher than the proportion found in the same national health survey, (69.4%) [20]. It should be noted that, rather than being overweight or obese, it plays a transcendental role in the development of cardiovascular disease, abdominal obesity, as it deepens the metabolic effects such as insulin resistance, glucose intolerance, hypertriglyceridemia, low HDL-c levels among others. The proportion of abdominal obesity observed in this study was 55.56% in total population, and by sex, it was higher in females (63.8%) than in men (36.8%) with significant difference. ENSANUT MC 2016 reported abdominal obesity 76.6% in total subjects studied, 65.4% in men and 87.7 % in women [20]. Although the proportion of subjects with abdominal obesity in this study was lower than ENSANUT MC 2016, when categorizing by sex, both studies were consistent with the higher prevalence of obesity in women with respect to men.
Other important study on cardiovascular risk factors in Mexican adult population, the “Lindavista Study”, conducted by Meaney and collaborators, identified abdominal obesity as the most common cardiovascular risk factor (61%), in the studied population [10]. The high proportion of overweight/obese individuals and specifically those observed with abdominal obesity could be related to inadequate eating habits and sedentary lifestyles, the latter reflected by the very low proportion of subjects who reported regular physical activity in this study, since in 74.07% of the individuals, sedentary lifestyle was identified; this percentage is higher than WHO estimation (60%) of global inactivity [21]. Sedentary lifestyle that is devoid of traditional diets, which have been replaced by hypercaloric diets rich in saturated fats, trans fats and refined sugars, also promotes the presence of other important CRFs such as insulin resistance (IR) [22,23].
As for the frequency of alterations in biochemical parameters, this study found hypercholesterolemia 48.14%, HDL-c levels 42.0%, raised LDL cholesterol 39.5%, triglycerides 50.6% and 38.27% of subjects with diabetes were identified; no significant gender differences were evident.
Meaney and collaborators in their Lindavista Study in Mexico refered to lower frequencies relative to this study in terms of hypercholesterolemia, 36%, elevated levels of c-LDL, 25%, hypertiglyceridemia (41%). With regard to the proportion of subjects with low HDL cholesterol levels, the same authors obtained 42%, coinciding with this research [10]. With respect to high blood pressure, the prevalence in Mexico, according to ENSANUT MC 2016 is 25.5%, in men 24.9% and in women 26.1% [20]; what this study showed, 34.57% of total population, 25.0% of men and 37.1% of women, exceeded mexican national estimates. 100% of the patients included in this study showed at least one risk factor for cardiovascular diseases, it should be noted that a maximum of nine risk factors were observed in 2.5% of the population. It is known that the coexistence of several risk factors produces a synergistic effect that results in an increase in overall risk for CVD [24].

Conclusion

A high frequency of cardiovascular risk factors was observed in the community studied, and an elevated trend to associate among them, denoting the need to develop strategies to address these health problems opportunely in these communities.

 

https://lupinepublishers.com/pharmacology-clinical-research-journal/pdf/LOJPCR.MS.ID.000125.pdf

https://lupinepublishers.com/pharmacology-clinical-research-journal/fulltext/cardiovascular-risk-factors-in-the-population-of-jamapa.ID.000125.php

For more Lupine Publishers Open Access Journals Please visit our website: https://lupinepublishersgroup.com/
For more Pharmacology & Clinical Research Please Click
Here: https://lupinepublishers.com/pharmacology-clinical-research-journal/
To Know more Open Access Publishers Click on Lupine Publishers


Follow on Linkedin : https://www.linkedin.com/company/lupinepublishers
Follow on Twitter   :  https://twitter.com/lupine_online

 


Tuesday, 8 September 2020

Lupine Publishers | -Dimer; A Potential Clinical Marker for Predicting Metastasis & Stages in Lung Cancer

 Lupine Publishers | LOJ Pharmacology & Clinical Research


Abstract

The relationship between plasma D-dimer level and the prognosis of advanced lung cancer is close to each other. This study investigated the role of plasma D-dimer as a prognostic factor in advanced lung cancer: a) The aim of the current study was to investigate the association of D dimer plasma level with the development of stages in lung cancer. b) D-dimers levels as predictor of fibrinolysis and Disseminated Intravascular Coagulation (DIC). The subjects were selected from oncology department, Ghulab Devi Hospital and Mayo Hospital, Lahore. Total 45 subjects were included in the present study. The selected subjects were divided into two groups. Group A included 15 normal, healthy, age and sex matched controls and group B included 30 patients, histologically diagnosed cases of lung cancer. The patients had no history of coagulation disorders or on anti-coagulant therapy. The plasma D-dimer was measured in normal, heathy Controls and 30 histologically diagnosed cases of lung cancer by enzyme-linked immunosorbent assay. The median age of the patients (18 males and 12 females ) was 39.433± 5.11 and 13.3% had stage lb, 20% had llb, 6.7 % llla, 36.11 lllb, 23.3 % had lV disease. Histologic sub-type was Non-small cell lung carcinoma (NSCLC) 30 %, Small cell lung carcinoma (SCLC) were 10 %, Squamous cell carcinoma were 10 %, adenocarcinoma 16.7 % and large cells carcinoma were 10%.In the present study. The Mean ± SD value of D-dimer level of the patients was 1068.70±441.86ng/dl, which was significantly higher than that of the control group. The plasma levels of D-dimer were significantly higher in patients with bronchogenic carcinoma as compared with healthy controls. Plasma D-dimer level was significantly higher in metastatic disease (P <0.01). D dimer levels were positively associated with clinical cancer stage (P<0.05) and metastasis (P<0.05). These findings suggested that the plasma D dimer level may be use as marker for predicting cancer metastasis and staging in lung cancer

Keywords:Lung Cancer; Malignancies; Haemostatic System; Coagulation; Tumor Cells; Hyper coagulopathy; D Dimer

Introduction

Lung cancer is one of the most prevalent malignancies in the world [1,2]. This cancer is currently the most common malignant disease and the leading cause of cancer related-deaths in all age groups and in both sexes [3]. The association between cancer and haemostatic system has been known since Trousseau’s study from the 19th century [4]. Coagulation or fibrinolytic system activation is present in lung cancer patients at clinical or subclinical level. There is a complex interaction, which has an important role in the course of the disease, between pathogenetic mechanisms of thrombosis, tumor cells, homeostatic systems, and patient characteristics. Patients with deep venous thrombosis (DVT) or subclinical hypercoagulopathy usually have worse prognosis. D-dimer is the cleavage product of cross linked fibrin that is formed by activation of the coagulation system, which signals hyperfibrinolysis in response to clot activation and fibrin formation [5]. Elevated levels of D-dimer have been detected in patients exhibiting diffuse intravascular coagulation [6], thromboembolic events, [7] D-dimer is a widely used biomarker for indicating the activation of coagulation and fibrinolysis [8,9]. Coagulation disorders are among the most common complications in cancer patients [8,10]. D-dimer is a degradation product of cross-linked fibrin that appears in the blood after a blood clot is degraded by fibrinolysis [11]. D-dimer is produced by fibrin degradation, and measurement of D-dimer levels can help in the diagnosis of thrombosis [12]. D-dimer levels have been found to be significantly higher in lung cancer with poor prognosis[13,14]. D-dimer is a plasmin-mediated degradation product of cross-linked fibrin clot, which is formed by the activation of the coagulation system for any reason [15]. Several studies suggested that serum D-dimer level may be an important parameter in assessing prognosis of disease and response to treatment in patients with lung cancer[14,16]. As D-dimer is a sensitive marker of fibrinolysis so, it is recommended measuring the plasma level of D-dimer in all new lung carcinoma patients [17]. The results suggested that the plasma level of D-dimer was notably associated with the extent of tumor metastasis and tumor stage in lung cancer patients.

Material and Methods

Total 45 subjects were included in the present study. 30 patients histologically diagnosed cases of bronchogenic carcinoma from oncology department, Ghulab Devi Hospital and Mayo Hospital Lahore, who were admitted between July 2017 to August 2018. The control group consisted of 15 healthy individual without co-morbidity. Lung cancer staging was performed for all patients according to the 7th TNM classification. The inclusion criteria were as following histological diagnosed cases of bronchogenic carcinoma pretreatment were selected. Patients with a history of venous thrombosis or anticoagulation therapy, hypertension, cardiovascular and cerebrovascular disease, diabetes, acute or chronic inflammatory disease, or previous malignancy were excluded from the current study. Written informed consent was obtained from each subjects before the sample collection. 3ml of venous blood was collected in the disposable syringe and put in to vacutainer tubes containing anticoagulant citrate buffer (1:9, buffer blood for D-dimers assay. History and clinical features were recorded in all subjects on performa. The principals of different tests and their procedures were adopted accordingly. Blood samples were centrifuged and the plasma was separated. D-dimer level was measured in the plasma, via enzyme-linked fluorescent immunoassay method using a PC-Vidas device (BioMerieux Fr). A D-dimer level <500 ng/dl was considered normal.

Results and Observations

Thirty patients with histological confirmed lung cancer were enrolled in the study. Mean age was 39.433 ± 5.11 years within the, range of 26-52 years, and there were 18 males (60.0%) and 12 females (40.0%). There were 05 (16.7%) adenocarcinomas, 10 (33.3%) squamous cell carcinomas, 03 (10.0%) small cell carcinomas and 09 (30%) non small cell carcinomas. 04 (13.3%) patients were classified as stage Ib, 06 (20%) patients as stage IIb, 02 (6.7%) patients as stage IIIa, 11 (36.7%) patients as stage IIIb and 07 (23.3%) patients as stage IV. The general characteristics of the lung cancer patients are shown in Table 1.

Discussion

The quotation “Qi is the commander of Blood and Blood acts as the mother of Qi” highlights the collaboration of Blood and Qi. Blood is seen as Yin and Qi can be classified into Yang, which can result in diseases when the imbalance of Yin-Yang occurs. Blood, produced with food qi (gu qi) by Spleen, circulates in the veins governed by Heart to nourish the organs and the systems. Blood, in addition to food qi, is also generated by the mother of Liver based on the Generating sequence Kidney, which stores prenatal Jing and produces marrow that generates to manufacture Blood. Qi circulates in the traditional twelve meridians to support the life, interacting with Blood for the Zang-Fu organs to function normally in harmony [20,21]. The studies on the relation between Qi in the twelve meridians and the oxygen metabolism highlight that one may be short of breath and experience wheezing or coughing when the normal level of blood oxygen is below, presenting the high similarity of physiological functions and pathological reactions between Qi and oxygen [22]. In other words, this suggested that oxygen, to some extent, is equivalent to Qi [23]. The Generating Sequence of the Five Elements theory shows Kidney is the mother of Liver, which suggests that Kidney’s problems can affect its child Liver. The maximum oxygen is delivered with the normal value of 45% of hematocrit [24]. Kidney produces Erythropoietin to promote the number of red blood cells to increase the capacity of the blood to carry more oxygen. In addition, the circulation of oxygen in the Kidney is closely associated with the production of Erythropoietin determined by tissue oxygen pressure [25]. In other words, stagnated Liver qi can be dispersed as long as Kidney can function normally with the delivery of the healthy Qi to Liver. In a word, the inflammation resulted from the infection can be reduced with much more oxygen delivered upwards with the blood to Lung.


D-dimer levels in patients with lung cancer were higher than those of the control group, and the difference was statistically significant P 0.05 (Table 2). D-dimer levels according to disease stage are shown in Table 3. When the D-dimer levels were compared according to disease stage in patients with lung cancer, a significant difference was observed between the D-dimer levels of patients with stage lb, llb and those with stage IV disease (P = 0.025). There was no significant difference between the other stage groups in terms of D-dimer levels. D-dimer levels were significantly higher in lung cancer patients than in the control group (P<0.01; Table 3). These data suggested that the plasma level of D dimer may be used as a marker of metastasis and staging in lung cancer.

Discussion

There is some evidence that the activation of coagulation and fibrinolytic system by neoplastic cells facilitates invasiveness and metastases [18]. Thus, the extent of such activation has been associated with tumor stage and prognosis in some malignancies such as breast, colorectal and lung cancer [19,20]. D-dimer is a product of cross-linked fibrin degradation by plasmin-induced fibrinolytic activity, and D-dimer levels are a biomarker of global hemostasis and fibrinolysis [21]. High D-dimer levels were associated with poor prognoses in patients with breast, [22,23] colon and rectum, [24,19] and lung [25,26] cancers. In the present study, it was demonstrated that elevated plasma levels of D dimer were associated with clinical cancer stages and metastasis in lung cancer patients. D-Dimers: In this study, D-dimers were found to be significantly increased (p < 0.01) in patients with lung cancer when compared with controls (Table 2). The D-dimer level was more in SCLC as compared to NSCLC. The increased D-dimer was more in Patients having DIC and in patients of metastatic disease. These increased levels of D-dimers may be due to enhanced fibrinolysis [27] in their study Showed increased levels of D-dimers in patients having malignancy. These findings are consistent with the results of [27,18,28,29]. Several studies have reported that plasma D-dimer levels were elevated and associated with the stage and mortality in lung cancer [28,29]. They also observed similar increase of D-dimers in lung cancer (2.0). Our study has some limitations. This is a retrospective observational study with small sample size. Therefore, the findings of this study need to be validated by prospective and multicentre studies. The present study thus provides more reference values for patients with later-stage tumors and poorer overall condition. SCLC is a highly invasive tumor with a poor prognosis, with different biological characteristics from NSCLC. Valid biomarkers are therefore needed to determine the prognosis of SCLC. In the present study, pretreatment plasma D-dimer levels were independently in patients with SCLC. This conclusion is supported by previous studies of lung cancer in general

Conclusion

The present study demonstrated that D-dimer plasma level was significantly higher in lung cancer patients and associated with clinical stages and metastasis. The current study was limited in that it only identified the association of D-dimer with tumor stage and metastasis.

 

https://lupinepublishers.com/pharmacology-clinical-research-journal/pdf/LOJPCR.MS.ID.000108.pdf

 https://lupinepublishers.com/pharmacology-clinical-research-journal/fulltext/d-dimer-a-potential-clinical-marker-for-predicting.ID.000108.php


For more Lupine Publishers  Open Access Journals Please visit our website:
To Know more Open Access Publishers Click on Lupine Publishers
Follow on Twitter   :  https://twitter.com/lupine_online